U.S. flag

An official website of the United States government

NC_000017.11:g.(?_31095030)_(31374155_?)dup AND Neurofibromatosis, type 1

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 17, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001033833.3

Allele description [Variation Report for NC_000017.11:g.(?_31095030)_(31374155_?)dup]

NC_000017.11:g.(?_31095030)_(31374155_?)dup

Genes:
EVI2A:ecotropic viral integration site 2A [Gene - OMIM - HGNC]
EVI2B:ecotropic viral integration site 2B [Gene - OMIM - HGNC]
OMG:oligodendrocyte myelin glycoprotein [Gene - OMIM - HGNC]
NF1:neurofibromin 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
17q11.2
Genomic location:
Chr17: 29422048 - 29701173 (on Assembly GRCh37)
Preferred name:
NC_000017.11:g.(?_31095030)_(31374155_?)dup
HGVS:
  • NC_000017.11:g.(?_31095030)_(31374155_?)dup
  • NC_000017.10:g.(?_29422048)_(29701173_?)dup

Condition(s)

Name:
Neurofibromatosis, type 1 (NF1)
Synonyms:
NEUROFIBROMATOSIS, TYPE I; Recklinghausen's disease; Von Recklinghausen disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0018975; MedGen: C0027831; Orphanet: 636; OMIM: 162200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001197140Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 17, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of large NF1 duplications reciprocal to NAHR-mediated type-1 NF1 deletions.

Kehrer-Sawatzki H, Bengesser K, Callens T, Mikhail F, Fu C, Hillmer M, Walker ME, Saal HM, Lacassie Y, Cooper DN, Messiaen L.

Hum Mutat. 2014 Dec;35(12):1469-75. doi: 10.1002/humu.22692.

PubMed [citation]
PMID:
25205021

NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?

Grisart B, Rack K, Vidrequin S, Hilbert P, Deltenre P, Verellen-Dumoulin C, Destrée A.

Eur J Hum Genet. 2008 Mar;16(3):305-11. doi: 10.1038/sj.ejhg.5201978. Epub 2008 Jan 9.

PubMed [citation]
PMID:
18183042
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001197140.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant results in a copy number gain of the genomic region encompassing the full coding sequence of the NF1 gene. The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. As the precise location of this event is unknown, it may be in tandem or it may be located elsewhere in the genome. While a whole gene duplication of NF1 alone has not been reported in the literature in individuals with NF1-related disease, microduplications spanning NF1 and the surrounding genomic region have been reported in individuals with variable developmental delay, intellectual disability, and a distinct absence of neurofibromas (PMID: 25205021, 22241097, 18183042, 27629806). These large multigenic duplications in NF1 appear to segregate with disease in several families although a few unaffected carriers have also been observed (PMID: 18183042, 22241097, 25205021). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024